Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Guidelines

Background:

• Bipolar disorder treatment guidelines evolve with new research.
• The Korean Medication Algorithm Project for Bipolar Disorder 2014 (KMAP-BP 2014) provides specific treatment recommendations.
• International guidelines offer varying approaches to bipolar disorder management.

Purpose of the Study:

• To compare KMAP-BP 2014 recommendations with other recent global bipolar disorder treatment guidelines.
• To identify similarities and differences in treatment strategies.
• To assess how KMAP-BP 2014 reflects current evidence-based practices.

Main Methods:

• Review of four recently published global treatment guidelines for bipolar disorder.
• Comparative analysis of KMAP-BP 2014 recommendations against international guidelines.
• Examination of first-line treatments for mania, dysphoric/psychotic mania, and maintenance phases.

Main Results:

• Initial mania treatment recommendations showed significant consistency across guidelines.
• Mood stabilizers (MS) and atypical antipsychotics (AAPs) were universally recommended for mania.
• Newer AAPs and lamotrigine were increasingly favored in later phases; KMAP-BP 2014 showed high concordance with global trends.

Conclusions:

• KMAP-BP 2014 recommendations are largely consistent with current international treatment guidelines for bipolar disorder.
• The findings reflect the growing influence of newer AAPs and updated research in clinical practice.
• Further research is necessary to address identified gaps and refine treatment algorithms.